Covishield will be commercialised once trials are successful: SII
New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely...
New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely...
New Delhi: Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark...
New Delhi: The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct...
New Delhi: The Serum Institute of India (SII) will launch the first Covid-19 vaccine called 'Covishield' and commence its trials...
New Delhi: The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of...